Stomach News and Research

RSS

URMC to trial minimally invasive device that 'reins in' acid reflux

The University of Rochester Medical Center (URMC) is one of 15 specialized sites across the U.S. and Europe gearing up to trial a new implantable device that could bring relief to the estimated 25 million American adults who suffer from daily heartburn.

4 Apr 2009

Researchers examine norovirus gastroenteritis

A new study from the University of Southampton is examining why norovirus gastroenteritis - popularly referred to as 'gastric flu' - is confined to specific parts of the small intestine.

1 Apr 2009

Maternal smoking replaces stomach sleeping as the greatest modifiable risk factor for SIDS

A study in the April 1 issue of the journal SLEEP shows that maternal smoking is associated with an impaired infant arousal process that may increase the risk for sudden infant death syndrome (SIDS).

1 Apr 2009

Heart burn surgery reverses chronic rejection in transplant patient

Acid reflux is thought to be - at most - an irritating condition easily controlled with medication, diet and weight loss.

1 Apr 2009

District Court decision received in Concerta patent sase

The U.S. District Court for the District of Delaware has rendered a decision in the patent litigation between Alza Corporation, McNeil-PPC, Inc. and Andrx Pharmaceuticals LLC. McNeil Pediatrics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., which markets Concerta (methylphenidate HCI) Extended-Release Tablets CII, said the court held that the patent in suit is not valid or infringed by the filing of Andrx's Abbreviated New Drug Application.

1 Apr 2009

Mother's dental hygiene may help reduce incidence of unknown complications in pregnancy

Bacteria from a mother's mouth can be transmitted through the blood and amniotic fluid in the womb to her unborn child.

30 Mar 2009

Drinking very hot tea increases risk of cancer of the oesophagus

People are advised to wait a few minutes before drinking a cup of freshly-boiled tea today as a new study, published on bmj.com, finds that drinking very hot tea (70°C or more) can increase the risk of cancer of the oesophagus, the muscular tube that carries food from the throat to the stomach.

29 Mar 2009

Rexahn Pharmaceuticals starts phase II pancreatic cancer trial

Rexahn Pharmaceuticals, Inc. has announced that it has received FDA approval to begin Phase II trials for Archexin, the Company's leading cancer compound, for the treatment of pancreatic cancer.

24 Mar 2009

Plastic protein protects bacteria from stomach acid's unfolding power

A tiny protein helps protect disease-causing bacteria from the ravaging effects of stomach acid, researchers at the University of Michigan and Howard Hughes Medical Institute have discovered.

23 Mar 2009

More cancer patients cured according to new data on cancer survival in Europe

New data and analyses from a long-running study of cancer survival in Europe have shown that the number of people actually cured of cancer - rather than just surviving for at least five years after diagnosis - is rising steadily.

23 Mar 2009

FDA warning on oysters recently harvested from Mississippi area 2C

The U.S. Food and Drug Administration is advising retailers and food service operators not to offer for sale oysters harvested between Feb. 24 and March 17, 2009, from Mississippi Area 2C, located in the Mississippi Sound portion of the Gulf of Mexico near Pass Christian, Miss. Further, consumers are advised not to eat such oysters.

22 Mar 2009

New type of yogurt fights bacteria that cause gastritis and stomach ulcers

Results of the first human clinical studies confirm that a new yogurt fights the bacteria that cause gastritis and stomach ulcers with what researchers describe as almost vaccine-like effects, scientists in Japan will report here today at the 237th National Meeting of the American Chemical Society.

22 Mar 2009

Gleevec reduces risk of cancer returning in patients with life-threatening gastrointestinal stromal tumors

Data published online and in an upcoming print issue of The Lancet show that Gleevec (imatinib mesylate) tablets, when taken after surgery, substantially reduces the rate of recurrence of Kit-positive gastrointestinal stromal tumors (GIST) compared with placebo.

20 Mar 2009

Study of Rituxan (rituximab) in lupus nephritis misses primary endpoint

Genentech, Inc. and Biogen Idec has announced that a Phase III study of Rituxan (rituximab) plus mycophenolate mofetil (MMF) and corticosteroids in patients with lupus nephritis did not meet its primary endpoint of significantly reducing disease activity at 52 weeks.

11 Mar 2009

New microgel capsules trap omega-3 fatty acids

Nutritionists are nearly unanimous in recommending that Americans should eat significantly more omega-3 fatty acids and consume them in foods, not in vitamin pills.

4 Mar 2009

Link between, bacteria, cancer explored with funding from American Cancer Society

The role of bacteria in the development of colorectal cancer is coming under scrutiny at the University of Rochester Medical Center, thanks to an $840,000 research award from the American Cancer Society.

3 Mar 2009

FDA requires boxed warning and risk mitigation strategy for metoclopramide-containing drugs

The U.S. Food and Drug Administration announced today that manufacturers of metoclopramide, a drug used to treat gastrointestinal disorders, must add a boxed warning to their drug labels about the risk of its long-term or high-dose use.

1 Mar 2009

Magnetic device studied as treatment for heartburn and acid reflux

More than 20 million Americans suffer from gastroesophageal reflux disease (GERD), experienced by many as chronic heartburn.

23 Feb 2009

First incisionless bariatric procedure performed in U.S.

Bariatric surgeons at Central Baptist Hospital made U.S. medical history Feb. 16 by performing a groundbreaking bariatric procedure to decrease the capacity of a patient's stomach without making a single incision into her body.

22 Feb 2009

Good bacteria may provide effective vehicle for an oral vaccine against anthrax

Researchers at North Carolina State University have discovered that the good bacteria found in dairy products and linked to positive health benefits in the human body might also be an effective vehicle for an oral vaccine that can provide immunity to anthrax exposure.

17 Feb 2009